can glp 1 prevent cancer GLP-1s may reduce risk for adults with obesity GLP-1 Receptor Agonists in Breast

May Reduce Inflammation Preliminary studies suggest that NNMT inhibition may lower systemic inflammation markers , helping reduce the oxidative stress burden that accelerates aging and disease progression

The injection site should be rotated regularly to prevent lipohypertrophy (fatty lumps) or lipoatrophy (fat loss), both of which can impair drug absorption

State Medicaid programs will also have access to these medications at these prices. CNBC reported on November 6, 2025, that Medicare will start covering obesity drugs for some patients for the first time starting mid-2026, a long-awaited move that could broaden the market for the medicines and spur more private insurers to cover them. A senior administration official explained the rationale to CNBC: We are constraining the access for patients that will benefit clinically from it, weve worked very hard to strike a balance between broad access that just makes sure to capture patients that will benefit clinically. Documentation of these qualifying conditions will be essential for coverage approval

This seemingly controversial impact of GLP-1RAs on DR may be because most trials focused on microvascular and cardiovascular outcomes rather than DR